Timely coverage of cleaning validation for the phamaceutical
industry, a dynamic area in terms of health-based limits. Author
encourages pharmaceutical manufacturers, and particularly upper
management, to meet the challenges of the science-based and
risk-based approaches to cleaning validation. Draws on the author's
vast experience in the field of cleaning validation and hazardous
materials Discusses EMA vs. ISPE on Cleaning Limits and revised
Risk-MaPP for highly hazardous products in shared facilities
Diverse list of topics from protocol limits for yeasts and molds to
cleaning validation for homeopathic drug products
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!